Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Texas
| Provider | Medicare | Services |
|---|---|---|
| Inform Diagnostics, Inc | $9.26 | 144 |
| Duran, Teresa M.D. | $3.34 | 131 |
| Almanza, Othon M.D. | $3.31 | 125 |
| Graham, Bradley MD | $11.60 | 113 |
| Trotter, Maureen MD | $3.34 | 91 |
| Clinical Pathology Laboratories,... | $13.14 | 90 |
| Lab Alliance Llc | $12.27 | 90 |
| Geldmeier, Gary M.D. | $10.04 | 86 |
| Berlingeri Ramos, Alma MD | $12.08 | 85 |
| Propath Services, Llc | $12.37 | 85 |
| Andino, Lizmarie M.D. | $3.67 | 76 |
| Krueger, Jo Ellen MD | $3.31 | 59 |
| Souchick, Ann Marie M.D. | $3.28 | 58 |
| Hardin, Justin MD | $3.37 | 56 |
| Ameripath Lubbock 5.01(A)... | $6.24 | 53 |
Texas Pricing in Context
In Texas, CPT code 88300 (Pathology Examination Of Tissue Using A Microscope, Limited Examination) carries an average Medicare payment of $4.11 — 5% above the national benchmark of $3.90. 792 providers across the state submitted claims for this procedure in 2023, performing 12.0K total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Texas is $58.12, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Pathology procedures, the estimated commercial insurance price in Texas lands near $12.10, with self-pay cash prices typically around $19.93. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Pathology Examination Of Tissue Using A Microscope, Limited Examination cost in Texas?
The average Medicare payment for Pathology Examination Of Tissue Using A Microscope, Limited Examination in Texas is $4.11, which is 5% above the national average of $3.90. Providers in TX typically bill $58.12 for this procedure.
What does Pathology Examination Of Tissue Using A Microscope, Limited Examination cost with insurance in Texas?
With commercial insurance in Texas, Pathology Examination Of Tissue Using A Microscope, Limited Examination costs an estimated $12.10. Without insurance, the estimated cash price is $19.93. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Pathology Examination Of Tissue Using A Microscope, Limited Examination in Texas?
792 providers in Texas billed Medicare for Pathology Examination Of Tissue Using A Microscope, Limited Examination in 2023, performing 12.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Pathology Examination Of Tissue Using A Microscope, Limited Examination cheaper in Texas than the national average?
No — Pathology Examination Of Tissue Using A Microscope, Limited Examination costs 5% above the national average in Texas. The state average Medicare payment is $4.11 compared to $3.90 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.